Your Article Summary
See Latest ArticlesAdherence to topical dermatological therapy: lessons from oral drug treatment
British Journal of Dermatology, 06/25/09
Gupta G et al. - The advent of new drug formulations that permit once-daily or single-dose drug application will, however, permit evaluation of different topical treatment regimens on adherence and treatment outcomes in patients with dermatological disease.
Related Articles
Single-institution Outcome of High-dose Interleukin-2 (HD IL-2) Therapy for Metastatic Melanoma and Analysis of Favorable Response in Brain Metastases
Anticancer Research, 11/11/09
Relevance Score: 66%
Paraneoplastic dermatological manifestation of gastrointestinal malignancies
World Journal of Gastroenterology, 10/01/09
Relevance Score: 66%
Optimizing regional infusion treatment strategies for melanoma of the extremities
Expert Review of Anticancer Therapy, 11/12/09
Relevance Score: 65%
A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma
Cancer, 11/09/09
Relevance Score: 65%
Melanoma Promotion after Photodynamic Therapy of a Suspected Bowen's Disease Lesion
Dermatology, 10/26/09
Relevance Score: 64%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Dapsone hypersensitivity syndrome in non-leprosy patients: A retrospective study of its incidence in a tertiary referral center in Taiwan
Journal of Dermatological Treatment , 12/11/09
Muscle Weakness After Repeated Injection of Botulinum Toxin Type A Evaluated According to Bite Force Measurement of Human Masseter Muscle
Dermatologic Surgery, 12/10/09
Randomized, Placebo-Controlled Study of a New Botulinum Toxin Type A for Treatment of Glabellar Lines: Efficacy and Safety
Dermatologic Surgery, 12/10/09